COMPANY PROFILE · /truveta
T
Truveta
Builds the world's largest and most diverse database of genotypic and phenotypic patient information to accelerate drug discovery and precision medicine. Aggregates real-world clinical and genomic data from healthcare providers to train AI models for patient stratification, biomarker discovery, and clinical trial recruitment.
Fresh · 5d ago
Latest valuation
~$1B+ (estimated post-Series C)
Annual Recurring Revenue
—
Headcount
~100-150 (estimated)
Funding total
$320M+
OVERVIEW
Series C ($320M, Jan 2025) launched company publicly. Positioned as foundational data infrastructure for precision medicine and drug discovery. One of largest digital health funding rounds of 2025.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.